Trial Profile
Planned phase II proof-of-concept trial of OTX 015 in haematological malignancies.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 09 Jul 2013
Price :
$35
*
At a glance
- Drugs Birabresib (Primary)
- Indications Haematological malignancies
- Focus Therapeutic Use
- 09 Jul 2013 New trial record